Nayak Tushar, Ojha Mukund Madhav, Ansari Mohd Akhtar, Sehrawat Sandeep, Shankar Vivek, Kumar Shailendra, Kumar Vijay
Orthopaedics, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Orthopaedics, All India Institute of Medical Sciences, Bathinda, Bathinda, IND.
Cureus. 2024 Oct 25;16(10):e72382. doi: 10.7759/cureus.72382. eCollection 2024 Oct.
Introduction The utilisation of transdermal patches containing buprenorphine (BTP) and ketoprofen (KTP) has been widely documented for post-operative pain management. However, to date, no single study has comprehensively evaluated the efficacy of KTP and BTP specifically in managing post-operative pain following arthroplasty procedures. Methods A total of 100 consecutive patients undergoing primary total knee replacement between August 2022 and January 2023 were randomly assigned into two groups (Group KTP and BTP) using computer-generated numbers. Patients in Group BTP received a buprenorphine patch (10 µg/h) 24 hours before surgery, replaced on the seventh day and sustained for 14 days. Group KTP received a ketoprofen patch (20 mg) on the day of surgery, replaced daily for 14 days. Pain intensity was assessed using the Visual Analog Scale (VAS) score pre-operatively and post-operatively. Clinical outcomes included VAS scores at baseline, on post-operative days (POD) 2, 5, and 14, both at rest and during activity, need for rescue analgesia, adverse events, duration of hospital stay, post-operative range of motion (ROM), and patient satisfaction. Results Results revealed significantly lower VAS scores at rest in the BTP group for the initial five days, with similar trends observed for VAS scores during activity. No significant differences were found in VAS scores at day 14. There was an increased need for rescue analgesia in the KTP group compared to the BTP group. Post-operative ROM was consistently higher in the BTP group, although not statistically significant. Patient satisfaction scores favoured the BTP group throughout admission, with no remarkable adverse effects in either group. Conclusion In conclusion, BTP patches demonstrated enhanced efficacy in managing post-operative pain compared to KTP, without exacerbating side effects in the early stages following total knee arthroplasty. BTP can be definitively considered as an adjuvant in post-operative total knee arthroplasty analgesia.
引言 含丁丙诺啡(BTP)和酮洛芬(KTP)的透皮贴剂在术后疼痛管理中的应用已有广泛记载。然而,迄今为止,尚无单一研究全面评估KTP和BTP在关节置换术后疼痛管理中的具体疗效。方法 2022年8月至2023年1月期间连续100例接受初次全膝关节置换术的患者,使用计算机生成的数字随机分为两组(KTP组和BTP组)。BTP组患者在手术前24小时接受丁丙诺啡贴剂(10 μg/h),在第七天更换,持续14天。KTP组患者在手术当天接受酮洛芬贴剂(20 mg),每天更换,持续14天。术前和术后使用视觉模拟量表(VAS)评分评估疼痛强度。临床结果包括基线、术后第2天、第5天和第14天静息和活动时的VAS评分、急救镇痛需求、不良事件、住院时间、术后活动范围(ROM)和患者满意度。结果 结果显示,BTP组最初五天静息时的VAS评分显著较低,活动时的VAS评分也有类似趋势。第14天的VAS评分无显著差异。与BTP组相比,KTP组急救镇痛需求增加。BTP组术后ROM始终较高,尽管无统计学意义。整个住院期间患者满意度评分有利于BTP组,两组均无明显不良反应。结论 总之,与KTP相比,BTP贴剂在全膝关节置换术后疼痛管理中显示出更高的疗效,且在早期阶段不会加重副作用。BTP可被明确视为全膝关节置换术后镇痛的辅助药物。